Header image
![](/sites/default/files/styles/page_header_image/public/2023-07/foto_zahlavi_research_1.jpg?itok=p7pBtlZR)
Journals
Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome.
Oncology Letters.
2017,
8(1),
1236,
ISSN: 1792-1074,
PMID: 29089570,
Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manne.
Toxicology and Applied Pharmacology.
2018,
355,
156-163,
ISSN: 0041-008X,
PMID: 29960002,